$8.42 Billion is the total value of NEA Management Company, LLC's 63 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 6.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ROBINHOOD MKTS INC | $3,148,358,000 | – | 74,818,398 | +100.0% | 37.40% | – | |
| BHG | BRIGHT HEALTH GROUP INC | $1,780,611,000 | -52.4% | 218,212,128 | 0.0% | 21.15% | -56.6% | |
| COUR | Sell | COURSERA INC | $502,215,000 | -23.5% | 15,867,769 | -4.4% | 5.97% | -30.3% |
| CVRX | CVRX INC | $392,140,000 | +490.7% | 2,370,858 | 0.0% | 4.66% | +438.5% | |
| New | BERKSHIRE GREY INC | $268,733,000 | – | 38,226,621 | +100.0% | 3.19% | – | |
| ALLK | ALLAKOS INC | $229,177,000 | +24.0% | 2,164,704 | 0.0% | 2.72% | +13.1% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $177,969,000 | -30.9% | 1,590,002 | 0.0% | 2.11% | -37.0% | |
| GLUE | MONTE ROSA THERAPEUTICS INC | $171,627,000 | -1.9% | 7,703,205 | 0.0% | 2.04% | -10.5% | |
| BILL | BILL COM HLDGS INC | $149,699,000 | +45.7% | 560,774 | 0.0% | 1.78% | +32.9% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $114,471,000 | +70.8% | 5,172,683 | 0.0% | 1.36% | +55.8% | |
| TRILLIUM THERAPEUTICS INC | $100,731,000 | +81.0% | 5,736,363 | 0.0% | 1.20% | +65.1% | ||
| NET | Sell | CLOUDFLARE INC | $100,231,000 | -65.7% | 889,759 | -67.8% | 1.19% | -68.7% |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $88,317,000 | +21.4% | 17,082,611 | 0.0% | 1.05% | +10.7% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $83,421,000 | +15.2% | 4,187,801 | 0.0% | 0.99% | +5.1% | |
| NKTX | NKARTA INC | $80,787,000 | -12.2% | 2,904,974 | 0.0% | 0.96% | -19.9% | |
| OYST | OYSTER PT PHARMA INC | $70,215,000 | -31.1% | 5,925,287 | 0.0% | 0.83% | -37.2% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $64,155,000 | -33.3% | 4,912,306 | 0.0% | 0.76% | -39.2% | |
| VECT | VECTIVBIO HLDG AG | $51,811,000 | +6525.4% | 67,069 | 0.0% | 0.62% | +6050.0% | |
| AKUS | AKOUOS INC | $49,905,000 | -7.5% | 4,298,488 | 0.0% | 0.59% | -15.6% | |
| VTGN | VISTAGEN THERAPEUTICS INC | $44,669,000 | -13.0% | 16,302,596 | 0.0% | 0.53% | -20.6% | |
| ANNX | Sell | ANNEXON INC | $43,894,000 | -21.9% | 2,358,606 | -5.6% | 0.52% | -28.8% |
| RPHM | RENEO PHARMACEUTICALS INC | $35,663,000 | -20.1% | 4,786,921 | 0.0% | 0.42% | -27.1% | |
| GRTX | GALERA THERAPEUTICS INC | $35,340,000 | -17.6% | 4,362,986 | 0.0% | 0.42% | -24.9% | |
| MILE | Sell | METROMILE INC | $33,314,000 | -61.2% | 9,384,285 | -0.0% | 0.40% | -64.6% |
| SVRA | SAVARA INC | $33,310,000 | -18.8% | 24,137,931 | 0.0% | 0.40% | -25.8% | |
| EAR | EARGO INC | $30,424,000 | -83.1% | 4,520,670 | 0.0% | 0.36% | -84.6% | |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $29,186,000 | -30.6% | 3,449,845 | 0.0% | 0.35% | -36.7% | |
| INZY | INOZYME PHARMA INC | $28,330,000 | -32.0% | 2,444,379 | 0.0% | 0.34% | -37.9% | |
| VRNA | VERONA PHARMA PLCads | $27,950,000 | -16.3% | 5,108,563 | 0.0% | 0.33% | -23.7% | |
| AFMD | AFFIMED NV | $27,356,000 | -27.3% | 4,426,488 | 0.0% | 0.32% | -33.7% | |
| CSPR | CASPER SLEEP INC | $26,586,000 | -48.2% | 6,226,130 | 0.0% | 0.32% | -52.7% | |
| BE | BLOOM ENERGY CORP | $24,960,000 | -30.3% | 1,333,333 | 0.0% | 0.30% | -36.6% | |
| AVEO | AVEO PHARMACEUTICALS INC | $24,429,000 | -6.2% | 3,952,958 | 0.0% | 0.29% | -14.5% | |
| MEIP | MEI PHARMA INC | $23,551,000 | -3.2% | 8,533,072 | 0.0% | 0.28% | -11.7% | |
| CTIC | CTI BIOPHARMA CORP | $21,064,000 | +18.0% | 7,140,450 | 0.0% | 0.25% | +7.3% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $20,662,000 | -16.4% | 6,643,704 | 0.0% | 0.24% | -23.9% | |
| GNCA | GENOCEA BIOSCIENCES INC | $19,924,000 | -17.9% | 10,376,936 | 0.0% | 0.24% | -25.0% | |
| GLYC | GLYCOMIMETICS INC | $19,904,000 | -5.6% | 9,089,041 | 0.0% | 0.24% | -14.2% | |
| GERN | GERON CORP | $18,442,000 | -2.8% | 13,461,538 | 0.0% | 0.22% | -11.3% | |
| IVA | Buy | INVENTIVA SAads | $18,390,000 | +29.4% | 1,298,700 | +24.7% | 0.22% | +17.8% |
| MRKR | MARKER THERAPEUTICS INC | $18,107,000 | -39.4% | 10,714,285 | 0.0% | 0.22% | -44.7% | |
| ARDX | ARDELYX INC | $17,996,000 | -82.6% | 13,633,582 | 0.0% | 0.21% | -84.1% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $17,497,000 | -0.7% | 1,713,720 | 0.0% | 0.21% | -9.2% | |
| IMRA | IMARA INC | $16,390,000 | -48.4% | 4,017,170 | 0.0% | 0.20% | -52.8% | |
| XENE | XENON PHARMACEUTICALS INC | $15,159,000 | -17.9% | 992,107 | 0.0% | 0.18% | -25.3% | |
| STSA | SATSUMA PHARMACEUTICALS INC | $14,646,000 | -33.9% | 3,142,958 | 0.0% | 0.17% | -39.8% | |
| OBSV | OBSEVA SA | $14,264,000 | +2.6% | 4,586,563 | 0.0% | 0.17% | -6.6% | |
| SYBX | SYNLOGIC INC | $12,900,000 | -21.6% | 4,229,410 | 0.0% | 0.15% | -28.5% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $11,459,000 | +4.8% | 2,382,286 | 0.0% | 0.14% | -4.2% | |
| MTCR | METACRINE INC | $10,506,000 | -9.7% | 3,062,977 | 0.0% | 0.12% | -17.8% | |
| DM | Sell | DESKTOP METAL INC | $10,330,000 | -95.4% | 14,407,594 | -25.8% | 0.12% | -95.8% |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $8,448,000 | -31.3% | 4,141,308 | 0.0% | 0.10% | -37.5% | |
| TRVI | TREVI THERAPEUTICS INC | $8,317,000 | -37.8% | 5,940,796 | 0.0% | 0.10% | -43.1% | |
| LQDA | LIQUIDIA TECHNOLOGIES INC | $6,862,000 | -3.5% | 2,486,062 | 0.0% | 0.08% | -11.8% | |
| LUMO | LUMOS PHARMA INC | $5,009,000 | -4.9% | 526,663 | 0.0% | 0.06% | -13.0% | |
| TRVN | TREVENA INC | $4,688,000 | -27.2% | 3,811,691 | 0.0% | 0.06% | -33.3% | |
| RGLS | REGULUS THERAPEUTICS INC | $4,455,000 | -14.7% | 6,451,056 | 0.0% | 0.05% | -22.1% | |
| ERYP | ERYTECH PHARMA SAadr | $3,606,000 | +19.4% | 625,000 | 0.0% | 0.04% | +10.3% | |
| TPST | TEMPEST THERAPEUTICS INC | $1,704,000 | +29.4% | 117,785 | 0.0% | 0.02% | +17.6% | |
| ADXN | ADDEX THERAPEUTICS LTDsponsored ads | $1,622,000 | -90.6% | 180,000 | 0.0% | 0.02% | -91.5% | |
| TCON | TRACON PHARMACEUTICALS INC | $1,342,000 | -40.4% | 346,718 | 0.0% | 0.02% | -44.8% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $737,000 | -5.8% | 452,167 | 0.0% | 0.01% | -10.0% | |
| VIRX | VIRACTA THERAPEUTICS INC | $297,000 | -29.5% | 37,093 | 0.0% | 0.00% | -20.0% | |
| UPST | Exit | UPSTART HLDGS INC | $0 | – | -287,092 | -100.0% | -0.47% | – |
| OPEN | Exit | OPENDOOR TECHNOLOGIES INC | $0 | – | -3,333,276 | -100.0% | -0.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.